In summary, the mitochondrial μ-calpain and AIF pathway is involved in the early stage of retinal degeneration in Rho transgenic S334ter and P23H rats, and inhibition of this pathway using Tat-μCL leads to effective treatment of RP involving Rho mutation. This evidence concerns the gene RHO and retinitis pigmentosa 1.